DeImplementing Ineffective and Low-Value Clinical Practices: Research and Practice Opportunities in Community Oncology Settings
- PMID: 33860151
- PMCID: PMC8036997
- DOI: 10.1093/jncics/pkab020
DeImplementing Ineffective and Low-Value Clinical Practices: Research and Practice Opportunities in Community Oncology Settings
Abstract
Patients, practitioners, and policy makers are increasingly concerned about the delivery of ineffective or low-value clinical practices in cancer care settings. Research is needed on how to effectively deimplement these types of practices from cancer care. In this commentary, we spotlight the National Cancer Institute Community Oncology Research Program (NCORP), a national network of community oncology practices, and elaborate on how it is an ideal infrastructure for conducting rigorous, real-world research on deimplementation. We describe key multilevel issues that affect deimplementation and also serve as a guidepost for developing strategies to drive deimplementation. We describe optimal study designs for testing deimplementation strategies and elaborate on how and why the NCORP network is uniquely positioned to conduct rigorous and impactful deimplementation trials. The number and diversity of affiliated community oncology care sites, coupled with the overall objective of improving cancer care delivery, make the NCORP an opportune infrastructure for advancing deimplementation research while simultaneously improving the care of millions of cancer patients nationwide.
Published by Oxford University Press 2021. This work is written by US Government employees and is in the public domain in the US.
Figures

Similar articles
-
Capacity for Cancer Care Delivery Research in National Cancer Institute Community Oncology Research Program Community Practices: Availability of Radiology and Primary Care Research Partners.J Am Coll Radiol. 2017 Dec;14(12):1530-1537. doi: 10.1016/j.jacr.2017.08.029. Epub 2017 Oct 19. J Am Coll Radiol. 2017. PMID: 29055605 Free PMC article.
-
Evolution of Cancer Care Delivery Research in the NCI Community Oncology Research Program.J Natl Cancer Inst. 2020 Jun 1;112(6):557-561. doi: 10.1093/jnci/djz234. J Natl Cancer Inst. 2020. PMID: 31845965 Free PMC article.
-
Defining the Role of the Advanced Practice Provider Within the National Cancer Institute Community Oncology Research Program.JCO Oncol Pract. 2024 Feb;20(2):239-246. doi: 10.1200/OP.23.00501. Epub 2024 Jan 4. JCO Oncol Pract. 2024. PMID: 38175992 Free PMC article.
-
The NCI Community Oncology Research Program: what every clinician needs to know.Am Soc Clin Oncol Educ Book. 2013. doi: 10.14694/EdBook_AM.2013.33.e84. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714464 Review.
-
National Cancer Institute: Restructuring to Support the Clinical Trials of the Future.Semin Oncol Nurs. 2020 Apr;36(2):151003. doi: 10.1016/j.soncn.2020.151003. Epub 2020 Apr 5. Semin Oncol Nurs. 2020. PMID: 32265163 Review.
Cited by
-
A mixed-methods study of multi-level factors influencing mammography overuse among an older ethnically diverse screening population: implications for de-implementation.Implement Sci Commun. 2021 Sep 26;2(1):110. doi: 10.1186/s43058-021-00217-7. Implement Sci Commun. 2021. PMID: 34565481 Free PMC article.
-
A systematic review of experimentally tested implementation strategies across health and human service settings: evidence from 2010-2022.Implement Sci. 2024 Jun 24;19(1):43. doi: 10.1186/s13012-024-01369-5. Implement Sci. 2024. PMID: 38915102 Free PMC article.
-
Four strategic areas to advance equitable implementation of evidence-based practices in cancer care.Transl Behav Med. 2021 Nov 30;11(11):1980-1988. doi: 10.1093/tbm/ibab105. Transl Behav Med. 2021. PMID: 34850931 Free PMC article. No abstract available.
-
De-implementing low-value care in cancer care delivery: a systematic review.Implement Sci. 2022 Mar 12;17(1):24. doi: 10.1186/s13012-022-01197-5. Implement Sci. 2022. PMID: 35279182 Free PMC article.
-
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans.J Clin Med. 2022 Nov 14;11(22):6738. doi: 10.3390/jcm11226738. J Clin Med. 2022. PMID: 36431215 Free PMC article.
References
-
- Cassel CK, Guest JA.. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307(17):1801–1802. - PubMed
-
- Berwick DM, Hackbarth AD.. Eliminating waste in US health care. JAMA. 2012;307(14):1513–1516. - PubMed
-
- Sparano J, Gray RJ, Wood WC, et al. TAILORx: phase III trial of chemoendocrine therapy versus endocrine therapy alone in hormone receptor-positive, HER2-negative, node-negative breast cancer and an intermediate prognosis 21-gene recurrence score. Paper presented at the American Society of Clinical Oncology Annual Meeting; June 3, 2018; Chicago, IL.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical